3 Large-Cap Stocks We Think Twice About
These trade-offs can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you find high-quality companies that can grow their earnings no matter what. Keeping that in mind, here are three large-cap stocks that may face near-term headwinds and some other investments you should consider instead.
Microchip Technology (MCHP)
Market Cap: $38.06 billion
Spun out from General Instrument in 1987, Microchip Technology (NASDAQ: MCHP) is a leading provider of microcontrollers and integrated circuits used mainly in the automotive world, especially in electric vehicles and their charging devices.
Why Do We Think MCHP Will Underperform?
Annual sales declines of 3.6% for the past five years show its products and services struggled to connect with the market during this cycle
Operating margin declined by 11.6 percentage points over the last five years as its sales cratered
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 16 percentage points
Microchip Technology is trading at $70.53 per share, or 62.5x forward P/E. Dive into our free research report to see why there are better opportunities than MCHP.
Danaher (DHR)
Market Cap: $145.3 billion
Born from a real estate investment trust that transformed into a manufacturing powerhouse, Danaher (NYSE:DHR) is a global science and technology company that provides specialized equipment, software, and services for biotechnology, life sciences, and diagnostics.
Why Does DHR Fall Short?
Products and services are facing significant end-market challenges during this cycle as sales have declined by 2.9% annually over the last two years
Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
7.9 percentage point decline in its free cash flow margin over the last five years reflects the company's increased investments to defend its market position
At $203 per share, Danaher trades at 25.1x forward P/E. Check out our free in-depth research report to learn more about why DHR doesn't pass our bar.
Regeneron (REGN)
Market Cap: $59.03 billion
Founded by scientists who wanted to build a company where science could thrive, Regeneron Pharmaceuticals (NASDAQ:REGN) develops and commercializes medicines for serious diseases, with key products treating eye conditions, allergic diseases, cancer, and other disorders.
Why Does REGN Give Us Pause?
Scale is a double-edged sword because it limits the company's growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 6.7% for the last two years
Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 12.3 percentage points
Waning returns on capital imply its previous profit engines are losing steam
Regeneron's stock price of $558.67 implies a valuation ratio of 14x forward P/E. To fully understand why you should be careful with REGN, check out our full research report (it's free).
High-Quality Stocks for All Market Conditions
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that's already erased most losses.
Don't let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results
Press Release – No. 11 / 2025 Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results Copenhagen, Denmark, August 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on August 14, 2025, at 2:00 pm CET (8:00 am ET) following the announcement of financial results for the second quarter of 2025. Participating in the call will be President and Chief Executive Officer, Adam Steensberg; Chief Financial Officer, Henriette Wennicke; Chief Medical Officer, David Kendall; and Chief Commercial Officer, Eric Cox. The presentation will be followed by a Q&A session. The live listen-only audio webcast of the call and accompanying slide presentation will be accessible at . To receive telephone dial-in information and a unique personal access PIN, please register at Participants are advised to register for the call or webcast approximately 10 minutes before the start. A recording of the event will be available following the call on the Investor section of Zealand Pharma's website at About Zealand Pharma A/SZealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma's business and activities, please visit ContactsAdam Lange (Investors)Vice President, Investor Relationsalange@ Neshat Ahmadi (Investors)Investor Relations Managerneahmadi@ Anna Krassowska, PhD (Investor and Media)Vice President, Investor Relations & Corporate Communicationsakrassowska@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a few seconds ago
- Yahoo
Strong Aerospace Performance Fuels Parker Hannifin To Record Profit
Parker Hannifin Corp. (NYSE:PH) stock is trading higher on Thursday after it reported fiscal fourth-quarter 2025 sales of record $5.24 billion, exceeding analyst expectations of $5.10 billion. Net income rose 18% year over year to $923 million, or $7.15 per diluted share, compared with $785 million, or $6.01 per share, a year ago. Adjusted earnings reached $992 million, or a record $7.69 per share, beating the consensus estimate of $7.11. In the Diversified Industrial segment, North America sales declined 6.9% to $2.08 billion, while segment operating margin expanded 200 basis points to 24.7%, or 170 basis points to 26.7% on an adjusted sales grew 4.3% to $1.49 billion, with margins improving 60 basis points to 22.4%, or 80 basis points to 24.7% adjusted. Order rates rose 2% in North America and remained flat internationally. Aerospace Systems revenue climbed 9.7% to $1.68 billion, driven by 8.6% organic growth. Segment operating income rose 23% to $407 million, while adjusted margin improved 190 basis points to a record 29.0%. The segment's backlog grew to a record $7.4 billion, with order rates up 12% year over year. For the full fiscal year, Parker reported revenue of $19.85 billion. Net income increased 24% to $3.53 billion, up from $2.84 billion in the prior year. Adjusted EPS was a record $27.33, rising 7% from $25.44. The full-year EBITDA margin reached 27.3%, or 26.4%, on an adjusted basis. View more earnings on PH Cash flow from operations increased 12% to $3.8 billion, or 19.0% of sales. Parker repurchased $1.6 billion in shares during the year, including $851 million in the fourth quarter. The company also raised its quarterly cash dividend by 10% and announced the acquisition of Curtis Instruments to expand its electrification capabilities. Parker ended the fiscal year with $467 million in cash and cash equivalents and $9.29 billion in total debt, including $1.79 billion due within one year. 'Looking ahead to fiscal year 2026, we expect Aerospace to remain our fastest growing business and see a return to positive organic growth in our Industrial businesses. We remain committed to being great generators and deployers of cash to drive shareholder value and look forward to another excellent year powered by our people and our business system,' commented Chairman and CEO Jenny Parmentier. Outlook For fiscal 2026, the company expects sales growth of 2%-5%, including approximately 3% organic growth at the midpoint. Segment operating margin is projected to range from 23.3% to 23.7%, or 26.3% to 26.7% on an adjusted basis. EPS guidance is between $24.68 and $25.68 versus the consensus of $25.778, and $28.40 to $29.40 on an adjusted basis versus the consensus of $28.873. Price Action: At last check Thursday, PH shares were trading higher by 3.18% to $719.29. Read Next:Photo by JHVEPhoto via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? PARKER HANNIFIN (PH): Free Stock Analysis Report This article Strong Aerospace Performance Fuels Parker Hannifin To Record Profit originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
2 minutes ago
- Business Wire
Blue Bird Delivers Electric School Bus Fleet to Little Rock School District in Arkansas
MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, is delivering 25 electric school buses to Little Rock School District (LRSD) in Arkansas. The zero-emission school bus fleet marks a new era of clean student transportation for the school district. LRSD is the third-largest school district in the state and operates more than 40 schools serving over 19,000 students. Blue Bird provides its most advanced Vision electric school buses to Little Rock School District. The state-of-the-art electric buses have a vehicle range of up to 130 miles on a single charge and can carry up to 69 passengers. The high-performance batteries take merely two hours to fully recharge. Following the completion of the Blue Bird electric school bus order, LRSD will maintain a bus fleet of approximately 70 vehicles. LRSD's zero-emission school buses will travel nearly 1,400 miles each school day, as they pick up and safely transport 500 students to and from schools. 'This is more than just adding new buses—it's about doing what's right for our kids and our community,' said Dr. Jermall D. Wright, superintendent of the Little Rock School District. 'We're proud to introduce Blue Bird's electric school buses as a step toward a cleaner, healthier future. Every mile these buses travel means less pollution, cleaner air, and a stronger commitment to the well-being of our students and the neighborhoods we serve.' 'We are pleased that Little Rock School District continues to place its trust in Blue Bird to help the school district shift to clean student transportation,' said Albert Burleigh, vice president of North America bus sales at Blue Bird Corporation. 'For more than 25 years, the school district has relied on Blue Bird and our local dealer partner to meet its school bus and service needs. We look forward to helping LRSD expand its school bus fleet with safe, reliable, and environmentally-friendly vehicles.' LRSD received a $9,875,000 grant through the U.S. Environmental Protection Agency's (EPA) widely popular and highly effective Clean School Bus Program to purchase its Blue Bird electric school bus fleet. The EPA has already awarded nearly $3 billion through the landmark bipartisan initiative. The program to date will enable more than 1,300 school districts nationwide to replace old diesel buses with nearly 9,000 electric and ultra-low emission vehicles. LRSD can considerably lower its operating expenses by replacing diesel with electric school buses due to reduced fuel and vehicle maintenance costs. School districts have reported paying a mere 19 cents per mile in energy costs for electric buses compared to fuel costs of up to 79 cents per mile for their diesel buses. Blue Bird is the only U.S.-owned and operated school bus manufacturer in the United States. The company remains the proven clean transportation leader with more than 2,500 electric-powered, zero-emission school buses in operation today. LRSD purchased its advanced electric-powered vehicles through Blue Bird's authorized school bus dealer Central States Bus Sales in North Little Rock, Ark. About Blue Bird Corporation Blue Bird (NASDAQ: BLBD) is recognized as a technology leader and innovator of school buses since its founding in 1927. Our dedicated team members design, engineer and manufacture school buses with a singular focus on safety, reliability, and durability. School buses carry the most precious cargo in the world – 25 million children twice a day – making them the most trusted mode of student transportation. The company is the proven leader in low- and zero-emission school buses with more than 25,000 propane, natural gas, and electric powered buses sold. Blue Bird is transforming the student transportation industry through cleaner energy solutions. For more information on Blue Bird's complete product and service portfolio, visit About the Little Rock School District The Little Rock School District (LRSD) is the state's third largest district, serving more than 19,000 students. The District has the distinction of having three national Blue Ribbon Schools of Excellence; nearly 200 teachers with National Board Certification; and historically within the past decade, the most National Merit Semifinalists in the state. LRSD is also home to the 2019 Arkansas Teacher of the Year and consistently ranks among the top award recipients in STEM-related competitions and the performing/creative arts. For more information, visit